Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States

Foresee Pharmaceuticals (6576.TWO) (“Foresee”) announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals (“Intas”) for the US commercialization of Foresee’s …
( read original story …)

---